675583-71-8

Basic information

• Product Name: 1H-Imidazole, 4-[[[(1,1-dimethylethyl)diphenylsilyl]oxy]methyl]-
• CAS NO: 675583-71-8
• Molecular Formula: C20H24N2OSi
• Molecular Weight: 336.509
• Mol File: 675583-71-8.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 1H-Imidazole, 4-[[[(1,1-dimethylethyl)diphenylsilyl]oxy]methyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Imidazole, 4-[[[(1,1-dimethylethyl)diphenylsilyl]oxy]methyl]-(675583-71-8)
• EPA Substance Registry System: 1H-Imidazole, 4-[[[(1,1-dimethylethyl)diphenylsilyl]oxy]methyl]-(675583-71-8)

Safety Data

• Hazardous Substances Data: 675583-71-8(Hazardous Substances Data)

Upstream product

• 822-55-9 (1H-imidazol-4-yl)methanol 
• 58479-61-1 tert-butylchlorodiphenylsilane 
• 32673-41-9 4-hydroxymethyl-1H-imidazole hydrochloride 

Downstream Products

• 924669-14-7 4-(4-tert-butyldiphenylsilyloxymethylimidazol-1-ylmethyl)benzoic acid methyl ester 
• 924669-15-8 4-(5-tert-butyldiphenylsilyloxymethylimidazol-1-ylmethyl)-benzoic acid methyl ester 
• 1331755-53-3 1-[4-(tert-butyldiphenylsilyloxymethyl)-1-(propen-2-yl)-1H-imidazol-2-yl]ethanone 
• 1331755-43-1 1-[4-(tert-butyldiphenylsilyloxymethyl)-1-vinyl-1H-imidazol-2-yl]ethanone 
• 1331755-44-2 1-[4-(tert-butyldiphenylsilyloxymethyl)-1-(2-fluoroethyl)-1H-imidazol-2-yl]ethanone 
• 1331755-45-3 4-(tert-butyldiphenylsilyloxymethyl)-1-vinyl-1H-imidazole 
• 1331755-46-4 5-(tert-butyldiphenylsilyloxymethyl)-1-vinyl-1H-imidazole 
• 1331755-42-0 4-(tert-butyldiphenylsilyloxymethyl)-1-(2-fluoroethyl)-1H-imidazole 
• 1331755-47-5 5-(tert-butyldiphenylsilyloxymethyl)-1-(2-fluoroethyl)-1H-imidazole 
• 1331755-35-1 4-(tert-butyldiphenylsilyloxymethyl)imidazole-1-sulfonic acid dimethylamide 
• 1331755-36-2 4-(tert-butyldiphenylsilyloxymethyl)imidazole-1-sulfonic acid dimethylamide 
• 1331755-52-2 4-(tert-butyldiphenylsilyloxymethyl)-1-(propen-2-yl)-1H-imidazole 

Relevant articles and documents

Synthetic models of the active site of cytochrome c oxidase: Influence of tridentate or tetradentate copper chelates bearing a his-tyr linkage mimic on dioxygen adduct formation by heme/cu complexes

Two synthetic models of the active site of cytochrome c oxidase-[(L N4-OH)CuI-FeII(TMP)]+ (1a) and [(LN3-OH)CuI-FeII(TMP)]+ (2a)-have been designed and synthesized. These models

DIAZEPINONE DERIVATIVES USEFUL FOR THE TREATMENT OF FRAGILE X SYNDROME, PARKINSONS OR REFLUX DISEASE

The invention relates to compound of the formula (I) or a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it.